Intellia Therapeutics, Inc 10-K for FY2023
Intellia Therapeutics, Inc. (NTLA)
10-K
2024-02-22
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Intellia Therapeutics, Inc filed this 10-K on February 22, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $36.28M
- down 30.4% from $52.12M a year earlier
- Net loss
- $481.19M
- compared with a net loss of $474.19M a year earlier
- Diluted EPS
- -$5.42
- compared with -$6.16 a year earlier